论文部分内容阅读
2019年12月一种新型冠状病毒感染引起的传染病在武汉及全国多地流行。国家卫生健康委员会于2020年1月20日发布1号公告，将新型冠状病毒感染的肺炎纳入传染病防治法规定的乙类传染病，采取甲类传染病管理。为有效控制传染源、切断传播途径、保护易感人群，保证医疗质量和医疗安全，切实做好疫情防控工作，全面保障医护人员、患者及家属的生命安全与身体健康，科学有序地组织开展核医学诊疗工作，根据国家防控政策，中华医学会核医学分会与《中华核医学与分子影像杂志》编辑委员会共同组织相关专家对在新型冠状病毒感染疫情期间，就核医学影像检查和核素治疗工作中的安全防护流程制订了本共识。“,”In December 2019, an infectious disease caused by a new type of coronavirus infection was prevalent in Wuhan and across the country. On January 20, 2020, the National Health Commission of the People′s Republic of China issued No. 1 Announcement, which incorporated the novel coronavirus pneumonia into the Class B infectious diseases according to the Law on Prevention and Control of Infectious Diseases, but the disease should be adopted the management of Class A infectious diseases. In order to effectively control the source of infection, cut off the transmission route, protect the susceptible population, ensure the medical quality and medical safety, effectively perform epidemic prevention and control, comprehensively guarantee the life safety and physical health of medical staff, patients and family members, it is very important to organize and carry out nuclear medicine diagnosis and treatment scientifically and safely. According to the national prevention and control policy, Chinese Society of Nuclear Medicine and Editorial Board of n Chinese Journal of Nuclear Medicine and Molecular Imaging organized professionals to formulate the expert consensus on the safety protection process of nuclear medicine imaging and nuclide therapy during the period of new coronavirus infection.n